Adult Migraine Hospital Admission Trends in Finland: A Nationwide Registry Study

Sipilä, Jussi; Ruuskanen, Jori O.; Rautava, Päivi; Kytö, Ville

doi:10.3390/jcm9020320

Cited by 3 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…pharmacy claims data, biospecimens, and neuroimaging data) might be included based on the aims of the registry. Several registries are currently available and in the last few years many publications have been made based on the data collected in these registries [143][144][145][146][147][148][149][150][151][152][153][154][155][156]: however, such an effort was partly thwarted by the inconsistency between the main elements in these registries, which will make it necessary to undertake harmonization procedures which will reduce the richness and complexity of the original information.…”

Section: Data and Information Systemsmentioning

confidence: 99%

The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders

Leonardi,

Martelletti,

Burstein

et al. 2024

J Headache Pain

View full text Add to dashboard Cite

The World Health Organization (WHO) Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders was developed by WHO to address the worldwide challenges and gaps in provision of care and services for people with epilepsy and other neurological disorders and to ensure a comprehensive, coordinated response across sectors to the burden of neurologic diseases and to promote brain health across life-course. Headache disorders constitute the second most burdensome of all neurological diseases after stroke, but the first if young and midlife adults are taken into account. Despite the availability of a range of treatments, disability associated with headache disorders, and with migraine, remains very high. In addition, there are inequalities between high-income and low and middle income countries in access to medical care. In line with several brain health initiatives following the WHOiGAP resolution, herein we tailor the main pillars of the action plan to headache disorders: (1) raising policy prioritization and strengthen governance; (2) providing effective, timely and responsive diagnosis, treatment and care; (3) implementing strategies for promotion and prevention; (4) fostering research and innovation and strengthen information systems. Specific targets for future policy actions are proposed. The Global Action Plan triggered a revolution in neurology, not only by increasing public awareness of brain disorders and brain health but also by boosting the number of neurologists in training, raising research funding and making neurology a public health priority for policy makers. Reducing the burden of headache disorders will not only improve the quality of life and wellbeing of people with headache but also reduce the burden of neurological disorders increasing global brain health and, thus, global population health.

show abstract

Section: Data and Information Systemsmentioning

confidence: 99%

The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders

Leonardi,

Martelletti,

Burstein

et al. 2024

J Headache Pain

View full text Add to dashboard Cite

show abstract

“…Interestingly, contemporary data also suggest that the disorder might be much more common (28% among women; 9% among men) in northern Finland [ 78 ]. Hospitalisation with a migraine as the main diagnosis has become more common, but this might be associated with stroke care as a migraine may mimic a stroke [ 79 ]. No epidemiological data on other primary headache disorders are available.…”

Section: Known Unknownsmentioning

confidence: 99%

Adult-Onset Neuroepidemiology in Finland: Lessons to Learn and Work to Do

Sipilä

2023

JCM

Self Cite

View full text Add to dashboard Cite

Finland is a relatively small genetic isolate with a genetically non-homogenous population. Available Finnish data on neuroepidemiology of adult-onset disorders are limited, and this paper describes the conclusions that can be drawn and their implications. Apparently, Finnish people have a (relatively) high risk of developing Unverricht-Lundborg disease (EPM1), Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Spinal muscular atrophy, Jokela type (SMAJ) and adult-onset dystonia. On the other hand, some disorders, such as Friedreich’s ataxia (FRDA) and Wilson’s disease (WD), are almost absent or completely absent in the population. Valid and timely data concerning even many common disorders, such as stroke, migraine, neuropathy, Alzheimer’s disease and Parkinson’s disease, are unavailable, and there are virtually no data on many less-common neurological disorders, such as neurosarcoidosis or autoimmune encephalitides. There also appear to be marked regional differences in the incidence and prevalence of many diseases, suggesting that non-granular nationwide data may be misleading in many cases. Concentrated efforts to advance neuroepidemiological research in the country would be of clinical, administrative and scientific benefit, but currently, all progress is blocked by administrative and financial obstacles.

show abstract

“…Chronic migraine patients, in particular, are not always correctly diagnosed within an acceptable time frame or adequately treated. Thus, the patient, who may not be properly informed on the use of medications and the correct pharmalogical treatment, may opt for an uncontrolled self-medication regimen, often ending up in an Emergency Department with a completely different life-threatening condition [9][10][11][12].…”

mentioning

confidence: 99%